Stratifying Fracture Risk to Guide Treatment Selection in Postmenopausal Osteoporsis

Please join us for an educational presentation on the treatment of patients with postmenopausal osteoporosis (PMO) at high risk for fracture.  Our presenter, Dr. Robert C. Hood, MD, FRCPC, FACE, will emphasize the importance of risk stratification when treating patients with PMO at very high risk for fracture according to AACE guidelines for PMO.  Situations when anabolic or antiresorptive therapy may be considered appropriate initial therapy option will also be discussed. Our business meeting will begin at 6:30 on Tuesday, August 13, 2024 before the presentation. We are looking forward to catching up with you all! The meeting room will be available at 6:00PM for early arrivals and networking.  I hope you are all staying hydrated, healthy, & happy!

Please RSVP to our website and to Stephanie Kirk  at 805-657-7727 or Email skirk@amgen.com